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Induction of double-strand DNA breaks (DSBs) by
engineered nucleases, such asCRISPR/Cas9 or tran-
scription activator-like effector nucleases (TALENs),
stimulates knockin of exogenous DNA fragments via
homologous recombination (HR). However, the
knockin efficiencies reported so far have not allowed
more complex in vitro genomemodifications such as,
for instance, simultaneous integration of a DNA frag-
ment at two distinct genomic sites. We developed a
reporter system to enrich for cells with engineered
nuclease-assisted HR events. Using this system in
mouse embryonic stem cells (mESCs), we achieve
single-step biallelic and seamless integration of two
loxP sites for Cre recombinase-mediated inducible
gene knockout, as well as biallelic endogenous
gene tagging with high efficiency. Our approach re-
duces the timeand resources required for conditional
knockout mESC generation dramatically.INTRODUCTION
The recent development of genome editing tools including
transcription activator-like effector nucleases (TALENs) and
CRISPR/Cas9 has enabled rapid and efficient targeted gene
disruption through error-prone non-homologous end joining
(NHEJ) repair of induced double-strand breaks (DSBs) (Joung
and Sander, 2013; Kim and Kim, 2014; Sander and Joung,
2014). However, this approach does not allow studying the
function of essential genes for which a conditional knockout
(cKO) strategy based on the Cre-loxP system is typically
used (Le and Sauer, 2000). This requires targeted integration
(knockin) of loxP sites via homologous recombination (HR)
and the expression of inducible Cre recombinase. A fusion
protein of Cre and a mutated ligand binding domain of human
estrogen receptor ERT2 is commonly used to control Cre ac-
tivity by 4-hydroxytamoxifen (4OHT), which promotes
CreERT2 translocation from the cytoplasm to the nucleus
where the Cre recognizes and recombines loxP sites
embedded in the genomic DNA (Feil et al., 1997). The 4OHT
controlled knockout induction allows us not only to select a
time window to study the function of an essential gene beforeit exerts a lethal phenotype, but also to assess the immediate
impact of a gene loss.
The conventional way of producing inducible cKO mouse
embryonic stem cells (mESCs) is very time consuming and
laborious and requires generation and crossing of mice carrying
the targeted cKO (loxP flanked) alleles (Friedel et al., 2011).
Recently, Cas9-stimulated integration of loxP-containing sin-
gle-stranded oligodeoxynucleotides (ssODNs) in mouse zygotes
simplified cKOmESC production but still relied on the use of live
animals (Wang et al., 2013). In order to follow the principles of
reducing the use of laboratory animals (Flecknell, 2002) and to
simplify and accelerate the process of cKO mESC creation, we
sought to improve the efficiency of engineered nuclease-medi-
ated HR events that would allow inserting the loxP sites directly
in mESCs. Here, we introduce a novel reporter system that
enables efficient single-step in vitro generation of cKO mESCs
and also biallelic endogenous gene tagging. The reporter system
is compatible with both TALENs and CRISPR/Cas9. Although
CRISPR/Cas9 technology has become prevalent due to its
ease of use, it can lead to off-target effects (Cradick et al.,
2013; Fu et al., 2013). This may be of particular concern when
a Cas9 guide RNA must target a defined genomic site for loxP
site integration or gene tagging, as this approach does not offer
the freedomof choosing an optimal guide RNA sequence. There-
fore, we employ the reporter system in combination with TALENs
because of their superior specificity (Kim and Kim, 2014).
RESULTS
Reporter System for TALEN-Mediated HR Events
Our approach is based on the previous finding that a reporter de-
signed to produce an EGFP signal upon NHEJ repair of a TALEN
cut can be used to enrich for cells with a TALEN-modified
genomic target site (Kim et al., 2011). We reasoned that a re-
porter relying instead on HR-mediated DSB repair would enrich
for cells with both the TALENs and the HR pathway being active,
which would in turn select for knockin clones such as those
required for generating cKO mESCs. Therefore, we adopted
the architecture of an existing HR-dependent b-galactosidase
reporter (Wefers et al., 2013) to create recombination reporter
plasmids (pRR-EGFP, pRR-Puro) that contain a prematurely
terminated N-terminal part of the EGFP or puromycin coding
sequence followed by a multiple cloning site (MCS) and a full-
length EGFP or puromycin coding sequence, respectively, with
a stop codon in place of a start codon (Figures 1A, S1A, andCell Reports 12, 709–716, July 28, 2015 ª2015 The Authors 709
Figure 1. Integration of CreERT2 and BirA into the Rosa26 Locus Using the pRR-Puro Reporter
(A) Schematic demonstration of TALEN-mediated pRR-Puro recombination. Red lined rectangles depict TALEN recognition sites. ELD, KKR, TALENs with
obligate heterodimeric FokI nuclease domain.
(B) Schematic overview of TALEN-assisted CreERT2 integration into theRosa26 locus. Colored arrows indicate positions of genotyping primers. AVsa, adenoviral
splice acceptor.
(C) PCR genotyping of Rosa26:CreERT2 insertions (upper panel) and Rosa26 wild-type allele (lower panel).
(D) Western blot analysis of CreERT2 expression in Rosa26CreERT2/- clones. Anti-tubulin staining serves as a loading control.
(E) PCR genotyping of Rosa26:BirA-V5 insertions (upper panel) and Rosa26 wild-type allele (lower panel). Positions of primers are depicted in Figure S3A.
(F) Western blot analysis of BirA-V5 expression in Rosa26BirA/- clones using an anti-V5 antibody.
(G) Summary of integration efficiencies in the Rosa26 locus using pRR-EGFP and pRR-Puro reporters.S1B). Upon insertion of a TALEN target sequence into the MCS
and co-transfection of this reporter plasmid with the respective
TALEN constructs, the TALEN-induced DSB in the plasmid is
anticipated to be repaired via recombination of the N-terminal
part with the homologous portion of the full-length sequence.
This results in functional EGFP or puromycin resistance, report-
ing on successful transfection, TALEN activity, and an effective
HR pathway.
Parental mESC Lines for the cKO Generation and
Endogenous Gene Tagging
To test the functionality of our reporter and to establish a parental
mESC line expressing 4OHT-inducible Cre for subsequent
cKO generation (RosaC), we employed pRR-EGFP to enrich
for TALEN-assisted integration of CreERT2 recombinase into
theRosa26 locus (Seibler et al., 2003) (Figure 1B). Using a TALEN
pair that targets the Rosa26 locus, we first optimized the length
of the N-terminal EGFP fragment needed for reporting TALEN-710 Cell Reports 12, 709–716, July 28, 2015 ª2015 The Authorsmediated HR. Whereas 400 nt homology yielded the highest
amount of EGFP-positive cells in the presence of TALENs, it
also produced detectable background fluorescence caused by
spontaneous recombination of the reporter. In contrast, 200 nt
homology resulted in fewer EGFP-expressing cells, but the
fluorescence was specifically induced by TALENs (Figure S1C).
To compare the performance of the two reporters with different
homology lengths,we co-transfected the pRR-EGFP400or pRR-
EGFP200 (400 or 200 nt N-terminal EGFP fragment, respectively)
with Rosa26 TALENs and a linearized CreERT2-Rosa26 HR
cassette, sorted the EGFP-positive cells by fluorescence-
activated cell sorting (FACS), and screened individual clones
by PCR genotyping for CreERT2 integration (Figure S2). We
obtained similar efficiency of z9% using either pRR-EGFP400
(four of 48 positive clones) or pRR-EGFP200 (two of 22 positive
clones).
Because transient puromycin selection has been shown to
outperform sorting of EGFP positive cells (Soldner et al., 2009),
Figure 2. Single-Step Generation of Cbx3 cKO mESCs
(A) Schematic overview of TALEN-assisted loxP-ssODN insertions into sites flanking Cbx3 exon 3. Colored arrows indicate positions of genotyping primers.
(B) PCR analysis of 4OHT-induced Cbx3 exon 3 deletion in RosaC(Cbx3loxP/loxP) clones after 48 hr of 4OHT treatment. Genomic DNA was amplified with primers
detecting the wild-type allele (upper panel) and primers spanning the loxP-flanked region (lower panel).
(C) Western blot analysis of 4OHT-induced HP1g depletion in RosaC(Cbx3loxP/loxP) clones after 48 hr of 4OHT treatment. Anti-FLAG antibody detects unwanted
stable 3xFLAG-tagged TALEN integration. Anti-tubulin staining serves as a loading control.we replaced the EGFP sequences in the pRR-EGFP200 re-
porter plasmid with a puromycin resistance gene, aiming at
increasing knockin efficiency (pRR-Puro, Figure 1A). Strikingly,
the use of pRR-Puro followed by 48 hr of puromycin treatment
resulted in a substantial increase of clones with integrated
CreERT2 when compared to pRR-EGFP. We obtained ten of
24 positive clones (42%), of which four clones were homozy-
gous (Rosa26CreERT2/CreERT2) (Figure 1C). Western blot analysis
confirmed CreERT2 protein expression in the heterozygous
clones (Rosa26CreERT2/-). Importantly, two of these clones
resumed puromycin sensitivity (Figure 1D), demonstrating that
our approach generates knockin cell lines without genomic
insertion of selectionmarkers. Besides eliminating potential con-
founding effects of marker gene insertions, the transient nature
of pRR-Puro selection enables multiple rounds of integrations
in the same cell line.
Using the same HR cassette, TALENs, and recombination
reporters, we observed comparable efficiencies when inserting
a V5-tagged BirA bacterial biotin ligase construct into the
Rosa26 locus (Figure S3A). The BirA-expressing cells (RosaB)
can be used as a parental line for endogenous gene tagging
with FLAG-AviTag, which is a well-established tagging system
for studying protein-protein or protein-chromatin interactions
in mESCs (Kim et al., 2009). EGFP-based selection resulted
in seven of 48 (14%) and four of 17 (23%) clones with inte-grated BirA when using pRR-EGFP400 and pRR-EGFP200,
respectively (Figure S3B). Consistent with the CreERT2 results,
puromycin selection with pRR-Puro boosted the enrichment
of BirA positive cells, yielding 13/24 (54%) positive clones of
which five appeared homozygous (Rosa26BirA/BirA) (Figure 1E).
We verified BirA expression in six heterozygous clones
(Rosa26BirA/-) by western blotting and found two of these
clones fully puromycin sensitive (Figure 1F). Together, these
results validate the efficacy of our recombination reporter in
enriching mESC clones with TALEN-mediated HR events and
show that pRR-Puro is approximately 3- to 4-fold more efficient
than pRR-EGFP (Figure 1G).
Generation of cKO mESCs in a Single Transfection Step
Insertion of loxP sites into mESCs for conditional knockout allele
generation is typically performed with an HR cassette carrying
both loxP sites flanking the targeted exon and long homology
arms on each side (Friedel et al., 2011). Because the cloning of
such constructs can be cumbersome, we tested whether this
can be circumvented by simultaneous integration of two inde-
pendent loxP-carrying ssODNs on both alleles in a single step.
To this end, we generated TALEN pairs targeting unique sites
flanking exon 3 of the Cbx3 gene, which codes for the HP1g pro-
tein (Figure 2A). We transfected RosaC cells (clone 23 from Fig-
ures 1C and 1D, Rosa26CreERT2/-) with the two TALEN pairs, theirCell Reports 12, 709–716, July 28, 2015 ª2015 The Authors 711
Figure 3. Endogenous HP1g Tagging with
FLAG-AviTag in RosaB Cells
(A) Schematic overview of TALEN-assisted inte-
gration of an ssODN carrying a FLAG-AviTag
sequence downstream of the Cbx3 start codon.
Colored arrows indicate positions of genotyping
primers.
(B) PCR genotyping of FLAG-AviTag insertions in
pRR-Puro selected clones with a reverse primer
binding in the AviTag sequence (upper panel) and
with primers spanning the integration site (lower
panel), where the expected PCR product size is
702 bp for the wild-type allele and 804 bp for the
allele containing the FLAG-AviTag sequence.
(C) Western blot analysis of RosaB
(Cbx3FLAG-AviTag/FLAG-AviTag) clones with anti-HP1g
antibody.
(D) Western blot detection of FLAG-AviTag-HP1g
protein in RosaB(Cbx3FLAG-AviTag/FLAG-AviTag) clones
with streptavidin-HRP and anti-FLAG antibody.
Anti-tubulin staining serves as a loading control.corresponding pRR-Puro reporters, and loxP-ssODNs. PCR
screening of 96 pRR-Puro selected clones revealed 29 clones
with loxP insertions, of which ten carried the loxP sequences
at both the 50 and 30 insertion sites (Figure S4A). Remarkably,
further genotyping of the ten double-positive clones revealed
four clones homozygous for the loxP insertion on both sites.
The remaining six clones were either heterozygous for one of
the insertions or contained a deletion of the whole fragment be-
tween the two TALEN cuts (Figure S4B). Thus, we obtained four
clones that are homozygous for the Cbx3 cKO allele in one step
with the pRR-Puro approach [RosaC(Cbx3loxP/loxP)]. In compari-
son, when using a plasmid that confers puromycin resistance
independently of TALEN activity and HR repair (i.e., this plasmid
solely reports transfection efficiency), we obtained only five
50-loxP and three 30-loxP positive clones out of 96 clones
screened, of which none had the loxP integrated on both sites712 Cell Reports 12, 709–716, July 28, 2015 ª2015 The Authors(Figure S4C). This demonstrates the su-
perior selective power of the pRR-Puro
reporter.
4OHT treatment of the four homozy-
gous Cbx3 cKO clones induced highly
effective Cre-mediated loxP-flanked
exon deletion, even at a very low concen-
tration of 0.1 mM, which is well below the
levels reported to cause cytotoxic effects
(Loonstra et al., 2001). PCR analysis of
genomic DNA after 48 hr of 4OHT treat-
ment showed complete excision of the
Cbx3 exon 3 (Figure 2B). Furthermore,
western blotting revealed nearly com-
plete loss of the HP1g protein 48 hr after
4OHT addition. Notably, in one of the
four clones we observed stable integra-
tion of the 3xFLAG-tagged TALEN
construct. This clone was also partially
resistant to puromycin (Figure 2C). The
other three clones were devoid of anyundesired plasmid integration. In summary, these results
demonstrate the feasibility of obtaining marker-less cKOmESCs
through a single transfection step.
Biallelic Endogenous Gene Tagging in mESCs
To validate the pRR-Puro utility on a different genomic site, we
tagged endogenous HP1g N-terminally with a FLAG-AviTag in
RosaB cells (clone 21 from Figures 1E and 1F, Rosa26BirA/-). We
co-transfected an ssODN carrying the FLAG-AviTag sequence
with a TALEN pair targeting theCbx3 start codon and the respec-
tive pRR-Puro plasmid (Figure 3A). Despite suboptimal TALEN
design due to the highly AT-rich property of the genomic target
site (Streubel et al., 2012), 16% of clones screened by PCR after
puromycin selectionwerehomozygous for theFLAG-AviTag inte-
gration (RosaB(Cbx3FLAG-AviTag/FLAG-AviTag); Figure 3B). Western
blot with an anti-HP1g antibody confirmed thatCbx3was tagged
on both alleles in three representative positive clones. The FLAG-
AviTag-HP1g protein was also readily detectable with strepta-
vidin-horseradish peroxidase (HRP) or an anti-FLAG antibody.
Furthermore, these clones resumed full puromycin sensitivity
and there was no indication of random genomic insertions of
the 3xFLAG-TALEN constructs (Figures 3C and 3D).
DISCUSSION
We have developed reagents and protocols for the in vitro
generation of marker-less cKO mESCs and endogenous gene
tagging. The method is based on recombination reporter plas-
mids that confer EGFP fluorescence or puromycin resistance
upon an engineered nuclease-induced DSB repair. Unlike previ-
ously published reporters, which rely on error-prone NHEJ repair
of a DSB to allow cell sorting, magnetic separation, or antibiotic-
based enrichment of cells with active nucleases (Kim et al., 2011,
2013), the reporters presented here become functional only after
repair by HR, thereby reporting on both the engineered nuclease
activity and the HR pathway activity simultaneously.
Our approach, for the first time, enables the bi-allelic flanking
of exons with loxP sites directly in mESCs in a single trans-
fection step. Using the herein established parental RosaC
(Rosa26CreERT2/-) cell line, cKOmESCs can be obtained in an un-
precedented time frame of less than 3 weeks in any laboratory
equipped for basic cell culture and molecular biology (Figure 4).
In contrast to targeted gene disruptions commonly induced by
TALE or CRISPR/Cas9 nucleases, the cKO strategy enables
loss-of-function analyses of essential genes. It also precludes
misinterpretation of observed knockout phenotypes that can
be caused by potential off-target effects associated with TALEN
or Cas9 genome editing (Frock et al., 2015; Kim and Kim, 2014).
The transient nature of our selection procedure avoids genomic
insertions of selection markers, enabling the generation of multi-
ple cKO alleles in the same cell line. Finally, we emphasize that
although we established our recombination reporter system in
combination with TALENs and mESCs, it might be equally
powerful in conjunction with the CRISPR/Cas9 system, and in
various cell types and organisms. Flexibility in choosing a partic-
ular genome-editing nuclease will be of particular importance
when sequence properties of the genomic target site may pre-
vent using one of the available genome editing systems.
EXPERIMENTAL PROCEDURES
Recombination Reporter Cloning
To generate the pRR-EGFP400 recombination reporter, a 400-bp N-terminal
portion of EGFP coding sequencewas PCR amplified from pEGFP-N1 plasmid
(Clontech Laboratories) using the forward primer ACGCTAGCGCTACCGG
TCGCCACCATGGT and the reverse primer AGGCGGCCGCTTGAGCTCT
CATTAGCCGTCCTCCTTGAAGTCG. The amplicon was digested with NheI/
NotI and inserted into NheI/NotI cut phRL-SV40 vector (Promega). The
resulting intermediate plasmid was digested with SacI/NotI. The full
EGFP coding sequence was then PCR amplified using the forward primer
ACGAGCTCTTGACGTCTAAGTGAGCAAGGGCGAGGAGC and the reverse
primer AGGCGGCCGCTTAGAGTCCGGACTTGTACAGCTCG, digested with
SacI/NotI, and inserted into the intermediate plasmid to obtain pRR-
EGFP400.
The EGFP N-terminal homology arms of 100 and 200 bp were amplified
using a common forward primer CTACCGGTCGCCACCATGGT and reverseprimers ACGAGCTCTCATTACCCTCGCCGGACACGCTG or ACGAGCTCT
CATTAGTAGGTCAGGGTGGTCACG. The amplicons were digested with
AgeI/SacI and inserted into AgeI/SacI cut pRR-EGFP400 to obtain pRR-
EGFP100 and pRR-EGFP200, respectively.
For pRR-Puro cloning, the puromycin N-acetyltransferase coding sequence
was first amplified with a forward primer ACCGAGTACAAGCCCAC
GGTGCGCCTCGCCACCCGCGACGATGTCCCCAGGGCCGTACGC and a
reverse primer GGCACCGGGCTTGCGGGTCATGCACCAGGTGCGCGGTCC
TTCGGGCACCTCTACGTCGGC to abolish internal AatII restriction sites. The
product was further amplified with a forward primer ACCAACGACGTCT
AAACCGAGTACAAGCCCACG and a reverse primer ACGCGGCCGCTCAGG
CACCGGGCTTGC, digested with AatII/NotI, and cloned into AatII/NotI cut
pRR-EGFP400. This intermediate plasmid was digested with NheI/AatII. The
200-bp Puro N-terminal homology part was PCR amplified from the intermedi-
ate plasmid using a forward primer ACCAACGCTAGCCACCATGACCGAGTA
CAAGCCCAC and a reverse primer CACTTAGACGTCAAGAGCTCTCAT
TACGCGACCCACACCTTGC, digested with NheI/AatII, and cloned into the
intermediate plasmid to obtain pRR-Puro. To clone individual TALEN-match-
ing reporters, the corresponding RR-oligos (listed in Table S1) were annealed
in annealing buffer (10 mM Tris-HCl [pH 7.5], 0.1 M NaCl, 1 mM EDTA) and
cloned into SacI/AatII cut pRR-EGFP or pRR-Puro.
Rosa26 Targeting Vector Cloning
To construct Rosa26 targeting vectors, Rosa26 homology arms from the Ai9
plasmid (Madisen et al., 2010) (Addgene 22799) were first subjected to PCR
with a reverse primer ACCAACTTAATTAAGAGGGGGAAGGGATTCTC for 50
arm and a forward primer ACCAACGGCGCGCCAGGCTTAAAGGCTAA
CCTGGTG for 30 arm to obtain homology arms lacking Rosa26 TALEN sites,
which were cloned back into Ai9 to produce Ai9noTAL. The CreERT2 coding
sequence was cloned from genomic DNA ofRosa26:CreERT2 ES cells (Seibler
et al., 2003) using a forward primer GCTTAATTAAGATATCCCTGCAGGGGT
GACCT and a reverse primer CCAGATGACTACCTATCCTCCCA. The product
was digested with PacI/AscI and inserted into PacI/AscI cut Ai9noTAL. The
BirA-V5 coding sequence was amplified from pEF1aBirAV5-neo plasmid
(Kim et al., 2009) using a forward primer ACGTCGACCATGAAGGATAAC
ACCGTGCCAC and a reverse primer ACACCGGTTCACGTAGAATCGAGA
CCGAGGAGA, digested with SalI/AgeI and cloned into SalI/AgeI cut
Ai9noTAL-CreERT2. The CreERT2 and BirA-V5 Rosa26 targeting cassettes
were then cut from Ai9noTAL with SacII/EcoRI and inserted into SacII/EcoRI
cut pBlu2KSM (Agilent Technologies) to obtain the final targeting vectors.
These were linearized with SacI and phenol-chloroform extracted prior to
transfection into ES cells.
TALEN Assembly
All TALENswere assembled using the Golden Gate TALEN cloning kit (Cermak
et al., 2011) (Addgene 1000000024) and previously described acceptor vec-
tors SV40-ELD and SV40-KKR carrying obligate heterodimeric FokI nuclease
domains (Flemr et al., 2013).
The following repeat variable diresidues were assembled for individual
TALENs:
Rosa26left-ELD (targeted sequence CCCTCGTGATCTGCAACT)
HD HD HD NG HD NN NG NN NI NG HD NG NN HD NI NI HD NG
Rosa26right-KKR (targeted sequence GCCCAGAAGACTCCCGCCCAT)
NN HD HD HD NI NN NI NI NN NI HD NG HD HD HD NN HD HD HD NI NG
Cbx3COND_50LOXleft-ELD (targeted sequence GTAGAATCCTGGGAAT)
NN NG NI NN NI NI NG HD HD NG NN NN NN NI NI NG
Cbx3COND_50LOXright-KKR (targeted sequence CTGAGAAATAATCTT)
HD NG NN NI NN NI NI NI NG NI NI NG HD NG NG
Cbx3COND_30LOXleft-ELD (targeted sequence AGAAGAGCATTACGT)
NI NN NI NI NN NI NN HD NI NG NG NI HD NN NG
Cbx3COND_30LOXright-KKR (targeted sequence CAAACTGGTTCA
CCAT)
HD NI NI NI HD NG NN NN NG NG HD NI HD HD NI NG
Cbx3N-TERMINALleft-ELD (targeted sequence GCAATAGCTCTT
CAAGTCT)
NN HD NI NI NG NI NN HD NG HD NG NG HD NI NI NN NG HD NGCell Reports 12, 709–716, July 28, 2015 ª2015 The Authors 713
Figure 4. Toolbox for Single-Step cKO Generation and Endogenous Gene Tagging in mESCs
(A) RosaC cells are heterozygous for Rosa26 promoter-drivenCreERT2, and they constitute a parental line for single-step cKOproduction. Using TALENswith our
pRR-Puro reporter, two ssODNs carrying loxP sites can be integrated simultaneously and biallelically in a single transfection reaction. The resulting conditional
allele carries a loxP-flanked exon within a gene of interest. Deletion of this exon is induced by 4OHT treatment, which causes CreERT2 relocation from the
cytoplasm to the nucleus and Cre-mediated excision of the loxP-flanked region.
(legend continued on next page)
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(C)Cbx3N-TERMINALright-KKR (targeted sequence GTAGTTTTATTGGA
GGCCAT)
NN NG NI NN NG NG NG NG NI NG NG NN NN NI NN NN HD HD NI NGCell Culture and Transfection
Mouse embryonic stem cells (129xC57Bl/6; Mohn et al., 2008) were cultured
on gelatin-coated dishes in mES medium (DMEM [Gibco 21969-035] supple-
mented with 15% fetal bovine serum [Biosera], 13 non-essential amino acids
[Gibco], 1 mM sodium pyruvate [Gibco], 2 mM L-glutamine [Gibco], 0.1 mM
2-mercaptoethanol [Sigma], 50 mg/ml penicillin, 80 mg/ml streptomycin and
home-made LIF conditioned medium) at 37C in 5% CO2. To induce recombi-
nation in Rosa26:CreERT2-expressing cells (RosaC), 4-hydroxytamoxifen
(Sigma) was added to the mES medium to a final concentration of 0.1 mM.
For integration in the Rosa26 locus with recombination reporters, 500,000
cells were seeded per well of a 6-well plate and transfected after 1 hr
with a transfection mixture consisting of 400 ng Rosa26left-ELD, 400 ng
Rosa26right-KKR, 200 ng pRR-EGFP or pRR-Puro, and 2 mg linearized
Rosa26 targeting vector.
To generate Cbx3 conditional knockout cells, the RosaC cells were trans-
fected with 250 ng of each Cbx3COND TALEN, 50 ng pRR-Puro-Cbx3_50LOX,
50 ng pRR-Puro-Cbx3_30LOX, 450 ng Cbx3_50LOX ssODN, and 450 ng
Cbx3_30LOX ssODN. When comparing pRR-Puro and TALEN-independent
puromycin reporter efficiencies, 100 ng of recombined pRR-Puro that con-
tained an intact functional puromycin resistance gene sequence was trans-
fected instead of pRR-Puro reporters. For endogenous HP1g tagging,
Rosa26:BirA-V5-expressing cells (RosaB) were transfected with 400 ng of
each Cbx3N-TERMINAL TALEN, 200 ng pRR-Puro-Cbx3N-TERM, and 1 mg
Cbx3-FLBIO ssODN. The ssODNs were synthesized as Ultramers by Inte-
grated DNA Technologies and their sequences are listed in Table S1.
All transfections were carried out using Lipofectamine 3000 reagent (Invitro-
gen) at 3 ml/1 mg DNA ratio in OptiMEM medium (Invitrogen).
Fluorescence Microscopy
Living cells transfectedwith pRR-EGFPwere imaged 24 hr post-transfection in
FlouroBrite DMEM medium (Invitrogen) on an Olympus iX-53 inverted micro-
scope using the Olympus U-FGFP filter cube.
Cell Sorting
Cells transfected with pRR-EGFP were trypsinized 24 hr post-transfection,
resuspended in PBS, and filtered through a 0.45-mm filter. EGFP-positive cells
were sorted on a BDFACSAria III cell sorter (Becton Dickinson) using a 488-nm
laser and collected in mES medium.
ES Cell Clone Selection and PCR Genotyping
Cells transfected with pRR-Puro reporters were selected by adding Puromycin
(2 mg/ml) to the mES medium 24 hr post-transfection. After 48 hr of selection,
surviving cells were trypsinized and plated at a clonal density in non-selective
medium on 10-cm dishes. (In the follow-up experiments, we noticed that 36 hr
of Puromycin selection are sufficient to kill all cells on the control plates and
that this shorter selection leads to lower incidence of stable Puromycin re-
porter integration.) Sorted EGFP-positive cells transfected with pRR-EGFP
were plated at a clonal density on 10-cm dishes. After 6 days of culture, indi-
vidual clones were picked and expanded in 96-well plates for 2 more days.
Cells were then washed with PBS and lysed directly in 96-well plates with
20 ml lysis buffer (10 mM Tris-HCl [pH 8.0], 0.5 mM EDTA, 0.5% Triton
X-100, and 0.5 mg/ml Proteinase K) for 2 hr at 55C in a humidified box. Pro-
teinase K was inactivated by incubating the lysates at 95C for 10 min and
0.5 ml of the lysate was directly used for PCR. A nested PCR in a 6-ml reaction
using QIAGEN Fast Cycling PCR Kit (QFC) and Q-solution (QIAGEN) was per-RosaB cells are a parental line for endogenous gene tagging, and they express
h the pRR-Puro reporter, an ssODN containing the FLAG-AviTag sequence ca
ciency. The resulting tagged endogenous protein is biotinylated by BirA, which
n be used to investigate the functional properties of the studied protein.
Schematic overview and timescale of single-step cKO mESCs generation anformed for Rosa26 integration genotyping. After a first round of 35 cycles with
0.5 mM R26pre5_F1 and Cre_R or BirA_R primers, the reaction was 153
diluted with water, and 0.5 ml was used for a second round of 35 cycles with
R26pre5_F2 and AVSA_R primers. All other genotyping was done in a single
35 cycle run in 6-ml reactions using QFC. The wild-type allele of Rosa26 was
amplified with R26_F and R26_R primers. LoxP integrations into the Cbx3
gene were screened with Cbx3_5F and LoxP_R primers for the 50LoxP and
with Cbx3_3F and LoxP_R primers for the 30LoxP. The region spanning
LoxP integrations was amplified with Cbx3_5F2 and Cbx3_5R2 primers for
the 50LoxP and with Cbx3_3F2 and Cbx3_3R2 primers for the 30LoxP. Cre-
mediated LoxP recombination in the Cbx3 gene was monitored with
Cbx3_5F and Cbx3_5R primers for the wild-type allele and with Cbx3_5F
and Cbx3_3R primers for the recombined allele. The FLBIO tag integration in
the Cbx3 gene was screened with Cbx3Nterm_F and FLBIO_R primers. The
region spanning the FLBIO integration was amplified with Cbx3Nterm_F and
Cbx3Nterm_R primers. Primer sequences are listed in Table S1.
Western Blotting
Cells were grown to confluency on 6-cm dishes, collected in PBS, and pelleted
by 2min centrifugation at 4003 g, and pellets were resuspended in 100 ml pro-
tein extraction buffer (50mMTris-HCl [pH 7.5], 150mMNaCl, 1%Triton X-100,
0.5 mMEDTA, and 5%glycerol) supplemented with 13 cOmplete Protease In-
hibitor Cocktail (Roche), 1 mM PMSF, and 1 mMDTT. Proteins were extracted
for 30 min on ice, the lysates were centrifuged at 16,0003 g for 20 min at 4C,
and protein concentration in the supernatant was determined using the Bio-
Rad protein assay. For western blotting, 20 mg of protein were resolved on
SDS-PAGE, semi-dry transferred on polyvinylidene fluoride (PVDF) mem-
brane, blocked for 30 min in 1% non-fat dry milk in TBS-0.05% Tween 20
(TBST), and stained with primary antibodies at 4C overnight. The primary an-
tibodies used for western blotting were rabbit-anti-Cre (1:5,000, Cell Signaling
Technology clone D3U7F), mouse-anti-V5 (1:5,000, Acris Antibodies), mouse
anti-FLAG (1:1,000, Sigma clone M2), mouse-anti-HP1g (1:2,000, Cell
Signaling Technology), and rat-anti-tubulin (1:5,000, Abcam clone YL1/2).
Signal was detected with corresponding HRP-conjugated secondary anti-
bodies and Immobilon Western Chemiluminiscent HRP Substrate (Millipore).
For streptavidin staining, membranes were blocked after transfer in 2% BSA
in TBST and incubated with streptavidin-HRP (1:25,000, Sigma) for 30 min
at room temperature, followed by signal development as above.
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